In Vitro Studies of Netilmicin, a New Aminoglycoside Antibiotic
Netilmicin, a semisynthetic derivative of sisomicin, was tested in vitro against 600 clinical bacterial isolates. At a concentration of 1.56 μg/ml, over 90% of gram-negative bacilli were inhibited. Netilmicin was substantially more active against isolates of Serratia marcescens and Enterobacter spp....
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1977
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352121/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/879746/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.6.1017 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|